-
1 Comment
IAG Holdings Limited is currently in a long term downtrend where the price is trading 42.7% below its 200 day moving average.
From a valuation standpoint, the stock is 1043.4% more expensive than other stocks from the Other sector with a price to sales ratio of 1.8.
IAG Holdings Limited's total revenue rose by 53.9% to $7M since the same quarter in the previous year.
Its net income has increased by 613.9% to $591K since the same quarter in the previous year.
Based on the above factors, IAG Holdings Limited gets an overall score of 2/5.
| Exchange | HK |
|---|---|
| CurrencyCode | HKD |
| ISIN | KYG4120P1046 |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | 124M |
|---|---|
| PE Ratio | None |
| Target Price | None |
| Beta | 0.25 |
| Dividend Yield | None |
MaxWin International Holdings Limited, an investment holding company, manufactures and sells injection molded plastic parts for disposable medical devices in Asia and Europe. The company operates through Component Parts; and Sub-Assembly Parts segments. It is also involved in the manufacturing and trading of medical component parts and sub-assembly parts; and provision of tooling services. In addition, the company manufactures plastics articles and products. The company was formerly known as IAG Holdings Limited and changed its name to MaxWin International Holdings Limited in October 2023. MaxWin International Holdings Limited was founded in 1981 and is headquartered in Singapore.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 8513.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
